Guangdong Kanghua Healthcare Group Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Guangdong Kanghua Healthcare Group.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Healthcare earnings growth | 22.1% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
There May Be Some Bright Spots In Guangdong Kanghua Healthcare Group's (HKG:3689) Earnings
Sep 30
Shareholders May Find It Hard To Justify Increasing Guangdong Kanghua Healthcare Co., Ltd.'s (HKG:3689) CEO Compensation For Now
Jun 19Does Guangdong Kanghua Healthcare (HKG:3689) Deserve A Spot On Your Watchlist?
Jun 10Guangdong Kanghua Healthcare Co., Ltd.'s (HKG:3689) Share Price Boosted 28% But Its Business Prospects Need A Lift Too
May 22Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal
Nov 28Returns On Capital Signal Tricky Times Ahead For Guangdong Kanghua Healthcare (HKG:3689)
May 09Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal
Feb 02Here's Why Guangdong Kanghua Healthcare (HKG:3689) Can Manage Its Debt Responsibly
Nov 08Some Investors May Be Worried About Guangdong Kanghua Healthcare's (HKG:3689) Returns On Capital
Sep 06Investors Could Be Concerned With Guangdong Kanghua Healthcare's (HKG:3689) Returns On Capital
May 31Returns On Capital Signal Tricky Times Ahead For Guangdong Kanghua Healthcare (HKG:3689)
Jan 25Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal
Sep 21Is Guangdong Kanghua Healthcare (HKG:3689) Using Too Much Debt?
May 03Do Insiders Own Lots Of Shares In Guangdong Kanghua Healthcare Co., Ltd. (HKG:3689)?
Feb 04
Key Things To Understand About Guangdong Kanghua Healthcare's (HKG:3689) CEO Pay Cheque
Dec 14In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Guangdong Kanghua Healthcare Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2024 | 2,039 | 51 | 93 | 190 | N/A |
| 3/31/2024 | 2,040 | 86 | 83 | 197 | N/A |
| 12/31/2023 | 2,042 | 121 | 73 | 204 | N/A |
| 9/30/2023 | 2,006 | 118 | 76 | 219 | N/A |
| 6/30/2023 | 1,970 | 115 | 80 | 234 | N/A |
| 3/31/2023 | 1,908 | 87 | 93 | 227 | N/A |
| 12/31/2022 | 1,846 | 60 | 106 | 221 | N/A |
| 9/30/2022 | 1,895 | 59 | 97 | 225 | N/A |
| 6/30/2022 | 1,945 | 59 | 87 | 228 | N/A |
| 3/31/2022 | 1,950 | 76 | 125 | 281 | N/A |
| 12/31/2021 | 1,954 | 94 | 162 | 333 | N/A |
| 9/30/2021 | 1,905 | 103 | 198 | 369 | N/A |
| 6/30/2021 | 1,856 | 112 | 233 | 405 | N/A |
| 3/31/2021 | 1,800 | 43 | 173 | 340 | N/A |
| 12/31/2020 | 1,745 | -25 | 113 | 275 | N/A |
| 9/30/2020 | 1,774 | -63 | -8 | 167 | N/A |
| 6/30/2020 | 1,802 | -100 | -128 | 59 | N/A |
| 3/31/2020 | 1,879 | -13 | -124 | 78 | N/A |
| 12/31/2019 | 1,956 | 74 | -121 | 98 | N/A |
| 9/30/2019 | 1,885 | 112 | -29 | 153 | N/A |
| 6/30/2019 | 1,815 | 150 | 62 | 207 | N/A |
| 3/31/2019 | 1,727 | 159 | 74 | 192 | N/A |
| 12/31/2018 | 1,639 | 168 | 87 | 177 | N/A |
| 9/30/2018 | 1,566 | 169 | 73 | 181 | N/A |
| 6/30/2018 | 1,492 | 170 | 59 | 185 | N/A |
| 3/31/2018 | 1,441 | 163 | N/A | 200 | N/A |
| 12/31/2017 | 1,389 | 157 | N/A | 214 | N/A |
| 9/30/2017 | 1,338 | 153 | N/A | 189 | N/A |
| 6/30/2017 | 1,287 | 149 | N/A | 163 | N/A |
| 3/31/2017 | 1,264 | 145 | N/A | 159 | N/A |
| 12/31/2016 | 1,240 | 141 | N/A | 155 | N/A |
| 12/31/2015 | 1,064 | 119 | N/A | 199 | N/A |
| 12/31/2014 | 985 | 102 | N/A | 206 | N/A |
| 12/31/2013 | 859 | 107 | N/A | 214 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 3689's forecast earnings growth is above the savings rate (2.3%).
Earnings vs Market: Insufficient data to determine if 3689's earnings are forecast to grow faster than the Hong Kong market
High Growth Earnings: Insufficient data to determine if 3689's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 3689's revenue is forecast to grow faster than the Hong Kong market.
High Growth Revenue: Insufficient data to determine if 3689's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 3689's Return on Equity is forecast to be high in 3 years time